Fujian Aonong Biological Technology Group Incorporation Limited (SHA:603363)
China flag China · Delayed Price · Currency is CNY
3.420
+0.040 (1.18%)
Apr 29, 2026, 3:00 PM CST

SHA:603363 Revenue

Fujian Aonong Biological Technology Group Incorporation had revenue of 2.21B CNY in the quarter ending March 31, 2026, with 23.71% growth. This brings the company's revenue in the last twelve months to 8.90B, up 9.33% year-over-year. In the year 2025, Fujian Aonong Biological Technology Group Incorporation had annual revenue of 8.47B, down -3.29%.

Revenue (ttm)
8.90B
Revenue Growth
+9.33%
P/S Ratio
1.00
Revenue / Employee
1.70M
Employees
4,900
Market Cap
8.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20258.47B-287.93M-3.29%
Dec 31, 20248.76B-10.69B-54.97%
Dec 31, 202319.46B-2.16B-9.97%
Dec 31, 202221.61B3.57B19.82%
Dec 31, 202118.04B6.52B56.62%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition